As more companies continue the return to in-person meetings, pharmaceutical event planners are finding new ways to help create memorable pharma events.

The COVID-19 pandemic has created myriad challenges for the meetings and events within the medical community…

January 2018 brought a new era of increased transparency and vetted ethics and compliance into the medical meetings industry.

Health care professional (HCP) attendance at life sciences company meetings has been healthy over the past several years.

Life can be challenging for corporate planners in a seller’s market, and especially so for many of those in the medical meetings sector.

A strong local medical community and suppliers who are certified and know the rules help cities become major players.

Concerns about optics have forced pharmaceutical companies to set limits on the amounts of money they can spend on hotel rooms, meals and other costs.

The advent of the Sunshine Act demonstrates a major shift in medical meeting planning that has been growing ever clearer in recent years.

Medical meetings may have survived the economic downturn, but 2013 brings additional challenges to pharma meetings in the name of the Affordable Care Act. The most sweeping federal health care legislation since Medicare in the 1960s, this controversial law has dominated political debates ever since its 2009 passage. Because most provisions of the law go […]

  “Here Comes the Sun” for the pharmaceutical meeting industry this year, as companies will have to report their payments and transfers of value made to physicians (of $10 or more) to the government under the Physician Payment Sunshine Act. According to the “final rule” issued by the Centers for Medicare and Medicaid Services (CMS) […]